Contribution of Lipoprotein(a) to polygenic risk of coronary artery disease: A prospective UK Biobank analysis

Back

ESC Professional Premium Access

Contribution of Lipoprotein(a) to polygenic risk of coronary artery disease: A prospective UK Biobank analysis

Session: Risk factors and prevention: lipids (3)

Topic: Lipids

Speaker: Doctor B. Arsenault (Quebec, CA)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Benoit Arsenault

Centre de Recherche de lInstitut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec (Canada)

0 follower

6 more presentations in this session

HDLc levels have a protective effect for in-hospital mortality in Non-STEMI but not in STEMI patients.

Speaker: Doctor A. Cordero (Elche, ES)

The distribution of lipoprotein(a) in Norway: a nationwide population-based study

Speaker: Ms J. Jeevanathan (Oslo, NO)

Real vs perceived LDL cholesterol control in clinical practice in Spain: Which factors are related to real control?

Speaker: Doctor J. Cosin Sales (Valencia, ES)

Longitudinal trajectories of lipid parameters and their associations with mid-life carotid intima-media thickness

Speaker: Mr A. Abdi (Tehran, IR)

Impact of ESC Guidelines implementation on lipid lowering strategy in a tertiary hospital cohort of STEMI patients: Can we aspire to do better than the EUROASPIRE V registry?

Speaker: Doctor M. Ferrer (Barcelona, ES)

Access the full session

Risk factors and prevention: lipids (3)

Speakers: Doctor B. Arsenault, Doctor A. Cordero, Ms J. Jeevanathan, Doctor J. Cosin Sales, Mr A. Abdi...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Contribution of Lipoprotein(a) to polygenic risk of coronary artery disease: A prospective UK Biobank analysis

About the speaker

Doctor Benoit Arsenault

6 more presentations in this session

HDLc levels have a protective effect for in-hospital mortality in Non-STEMI but not in STEMI patients.

The distribution of lipoprotein(a) in Norway: a nationwide population-based study

Real vs perceived LDL cholesterol control in clinical practice in Spain: Which factors are related to real control?

Longitudinal trajectories of lipid parameters and their associations with mid-life carotid intima-media thickness

Impact of ESC Guidelines implementation on lipid lowering strategy in a tertiary hospital cohort of STEMI patients: Can we aspire to do better than the EUROASPIRE V registry?

Access the full session

Risk factors and prevention: lipids (3)

About the event

ESC Congress 2023

ESC 365 is supported by